media – Page 632 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Ddu Attended CPhI Worldwide in Germany, Gaining Attention from the Whole Industry

The International Pharmaceutical Networking Exhibition (CPhI Worldwide 2017), was held at Ludwig-Erhard-Anlage 1 in Messe, Frankfurt, Germany from the 24th to the 26th of October 2017. As the leading global pharmaceutical & medical device B2B online platform, Ddu attended the exhibition, gaining attention from the whole industry.
- Source: Ddu
- 1,618
- October 31, 2017
CPhI Worldwide 2017 Exhibitions & Activities
FDA Calls BioMarin’s Hemophilia A Drug a Breakthrough

BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted its valoctocogene roxaparvovec for Hemophilia A Breakthrough Therapy Designation.
- Source: biospace
- 815
- October 31, 2017
Clinical Trial FDA hemophilia A
How flu shot manufacturing forces influenza to mutate

According to a new study from scientists at The Scripps Research Institute (TSRI), the common practice of growing influenza vaccine components in chicken eggs disrupts the major antibody target site on the virus surface, rendering the flu vaccine less effective in humans.
- Source: Medicalxpress
- 878
- October 31, 2017
antibody influenza vaccine
CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

Prospects for GlaxoSmithKline’s new shingle vaccine Shingrix have been raised after US advisors recommended that it should be used instead of rival Zostavax from Merck & Co.
- Source: Pmlive
- 936
- October 30, 2017
Company Insight HIV Shingrix Tivicay Triumeq vaccine
Pfizer to launch consumer health sale in November

Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters.
- Source: Pharmacodia
- 634
- October 30, 2017
Consumer Healthcare Market Views pill
Oral Drug Beats Interferon in First Pediatric MS Trial

In the first randomized controlled trial in pediatric multiple sclerosis, fingolimod (Gilenya) significantly cut relapses compared with interferon beta-1a (Avonex), researchers reported here.
- Source: medpagetoday
- 660
- October 30, 2017
beta-1a Clinical Trials interferon multiple sclerosis pediatric
Surgeon diagnoses his own cancer with an iPhone

US vascular surgeon John Martin found cancerous cells in his own neck while testing a portable ultrasound device called Butterfly iQ.
- Source: cnet
- 530
- October 30, 2017
Butterfly iQ cancer Market Views ultrasound
Alzheimer’s–Brain’s protective mechanism revealed

Buildups of "clumpy" proteins in the brain are well-known hallmarks of Alzheimer's, but not everyone who has them goes on to develop this neurodegenerative disease. Why is that? New research investigates.
- Source: medicalnewstoday
- 631
- October 30, 2017
Alzheimer's dendritic spines neurodegenerative Researches
Shire Receives European Approval for Label Extension of FIRAZYR® (icatibant injection) for the Symptomatic Treatment of Acute HAE Attacks in Paediatric Patients

Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in serving patients with rare diseases, announced today that the European Commission (EC) has approved a label extension granting a new indication for FIRAZYR® (icatibant injection), broadening its use to adolescents and children aged 2 years and older, with hereditary angioedema (HAE) caused by C1-esterase-inhibitor (C1-INH) deficiency. FIRAZYR has been approved in the European Union (EU) since 2008 for symptomatic treatment of acute attacks of HAE in adults with C1-INH deficiency.
- Source: finance.yahoo
- 544
- October 30, 2017
EC FIRAZYR® HAE Shire
US FDA finalises new guidelines for medical device development

The US Food and Drug Administration (FDA) has announced new measures to promote medical device innovation and provide patients with fast access to beneficial technologies.
- Source: medicaldevice-network
- 473
- October 30, 2017
FDA medical device

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.